{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:21:43Z","timestamp":1744161703008},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":3271,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.jacc.2004.03.079","type":"journal-article","created":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T19:25:31Z","timestamp":1093375531000},"page":"635-641","source":"Crossref","is-referenced-by-count":29,"title":["Co-Administration of Nitric Oxide-Aspirin (NCX-4016) and Aspirin Prevents Platelet and Monocyte Activation and Protects Against Gastric Damage Induced by Aspirin in Humans"],"prefix":"10.1016","volume":"44","author":[{"given":"Stefano","family":"Fiorucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mencarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Meneguzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Lechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Renga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"del Soldato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Minuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2004.03.079_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrd794","article-title":"Potential cardioprotective actions of NO-releasing aspirin","volume":"1","author":"Wallace","year":"2002","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.jacc.2004.03.079_bib2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1055\/s-0038-1650662","article-title":"The antiplatelet effects of a new nitroderivative of acetylsalicylic acid","volume":"76","author":"Lechi","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.03.079_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0049-3848(98)00134-0","article-title":"In vivo antithrombotic effects of a nitric oxide-releasing aspirin derivative, NCX-4016","volume":"93","author":"Wallace","year":"1999","journal-title":"Thromb Res"},{"key":"10.1016\/j.jacc.2004.03.079_bib4","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/gast.2003.50096","article-title":"Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers","volume":"124","author":"Fiorucci","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2004.03.079_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.03.079_bib6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2004.03.079_bib7","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.141126698","article-title":"Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor","volume":"98","author":"Riewald","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacc.2004.03.079_bib8","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.98.17.1776","article-title":"Enhanced monocyte tissue factor response after experimental balloon angioplasty in hypercholesterolemic rabbit","volume":"98","author":"Corseaux","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaques","volume":"95","author":"Toschi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib10","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1182\/blood.V94.10.3413.422k24_3413_3420","article-title":"Tissue factor and factor VIIa receptor\/ligand interactions induce proinflammatory effects in macrophages","volume":"94","author":"Cunningham","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2004.03.079_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.bjp.0704326","article-title":"NCX4016 (NO-aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes","volume":"134","author":"Minuz","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacc.2004.03.079_bib12","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.4049\/jimmunol.165.9.5245","article-title":"IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin","volume":"165","author":"Fiorucci","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jacc.2004.03.079_bib13","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1161\/01.CIR.0000039341.57809.1E","article-title":"NCX-4016 (NO-aspirin) inhibits lipopolysaccharide-induced tissue factor expression in vivo","volume":"106","author":"Fiorucci","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"354","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.03.079_bib15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199110173251605","article-title":"Suppression of thromboxane A2but not of systemic prostacyclin by controlled-release aspirin","volume":"325","author":"Clarke","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.03.079_bib16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib17","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.CIR.96.4.1109","article-title":"Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina","volume":"96","author":"Cipollone","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib18","doi-asserted-by":"crossref","first-page":"10937","DOI":"10.1073\/pnas.1933204100","article-title":"Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa","volume":"100","author":"Fiorucci","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jacc.2004.03.079_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(00)00223-5","article-title":"Prevention of pulmonary thromboembolism by NCX 4016, a nitric oxide-releasing aspirin","volume":"397","author":"Momi","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jacc.2004.03.079_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4049\/jimmunol.163.2.963","article-title":"Lipopolysaccharide modulates cyclooxygenase-2 transcriptionally and posttranscriptionally in human macrophages independently from endogenous IL-1 beta and TNF-alpha","volume":"163","author":"Barrios-Rodiles","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jacc.2004.03.079_bib21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-0038-1657623","article-title":"Regulation of tissue factor gene","volume":"78","author":"Mackman","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.03.079_bib22","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/01.CIR.101.18.2144","article-title":"Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide","volume":"101","author":"Yang","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib23","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/01.ATV.20.10.2322","article-title":"Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression","volume":"20","author":"Lindmark","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2004.03.079_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1650226","article-title":"The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay","volume":"75","author":"Amirkhosravi","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2004.03.079_bib25","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.CIR.0000028590.02477.6F","article-title":"Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointimal formation after arterial injury","volume":"106","author":"Schober","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/29788","article-title":"Decreased lesion formation in CCR2 -\/- mice reveals a role for chemokines in the initiation of atherosclerosis","volume":"394","author":"Boring","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2004.03.079_bib27","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1161\/01.CIR.0000018603.67989.71","article-title":"Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits","volume":"105","author":"Mori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib28","doi-asserted-by":"crossref","first-page":"28568","DOI":"10.1074\/jbc.272.45.28568","article-title":"Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle cells and THP-1 cells","volume":"272","author":"Schecter","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacc.2004.03.079_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation","volume":"96","author":"De Caterina","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2004.03.079_bib30","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.CIR.102.7.806","article-title":"Increased activity of nuclear factor-kB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats","volume":"102","author":"Kitamoto","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2004.03.079_bib31","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0016-5085(99)70012-0","article-title":"Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats","volume":"116","author":"Fiorucci","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2004.03.079_bib32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJM200009213431202","article-title":"Nitrovasodilators, low-dose aspirin, other antiinflammatory drugs and the risk of upper gastrointestinal bleeding","volume":"343","author":"Lanas","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2004.03.079_bib33","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704010022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109704010022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T06:46:42Z","timestamp":1682750802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109704010022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0735109704010022"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2004.03.079","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}